MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0242176
Precia Pharma Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹5.77 Cr
▼ 53% YoY
Net loss · FY 2023
₹3.23 Cr
Net margin -56.1%
EBITDA · FY 2023
-₹2.51 Cr
EBITDA margin -43.6%
Authorised capital
₹4.5 Cr
Registered with MCA
Paid-up capital
₹4.31 Cr
Issued & subscribed
Open charges
₹6.65 Cr
Satisfied ₹80 Lakh
Company age
16 yrs
Est. 2010
Employees · EPFO
1
Provident fund records
About Precia Pharma Private Limited
Data last updated:
Precia Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 May 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2010PTC203201. Its GSTIN is 27AAFCP7123F1ZI (Maharashtra). The company holds 7 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹4.31 Cr. It was formerly known as Precia Phama Private Limited. It is led by directors Sanjay Marotrao Pawar (Managing Director) and Anil Marotrao Pawar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2023, the company reported a revenue of ₹5.77 Cr, a decline of 53% compared to the previous year. For the same year it recorded a net loss of ₹3.23 Cr (net margin -56.1%) and EBITDA of -₹2.51 Cr (EBITDA margin -43.6%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 22% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
The company is associated with 1 brand: Precia Pharma. As per MCA filings, the company has open charges of ₹6.65 Cr and satisfied charges of ₹80 Lakh on record. Court records list 25 cases involving the company, including 25 filed against it; 8 cases are pending. The company has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹2.5 Cr; the latest was in March 2016. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is Nucleus Formulation Private Limited with revenue of ₹5.79 Cr.
Precia Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0242176). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website preciapharma.com.
Company details
CIN U24233MH2010PTC203201
Registration Number 203201
Incorporation Date 14 May 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0242176
Recognitions & Rankings of Precia Pharma
Contact details
Precia Pharma Private Limited's registered office is in Thane, Maharashtra. Its website is preciapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressBl Dg – D – 4 Flat – 502 Laxmi Narayan Residency Pokhran Road No, . 1, Thane, Maharashtra, India – 400606
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Precia Pharma Private Limited, buy the company report.
Comprehensive company report
Precia Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Precia Pharma operates one associated brand: Precia Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Precia Pharma focuses on branded prescription pharmaceuticals for lifestyle disease management, including diabetes and neuropathy treatments. | preciapharma.com |
Business activity
The main business activity of Precia Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Precia Pharma Private Limited, buy the company report.
Financials of Precia Pharma Private Limited
FY 2023 filings availablePrecia Pharma Private Limited reported revenue of ₹5.77 Cr (down 53% YoY) for FY 2023.
Revenue · FY 2023
₹5.77 Cr ▼ 53%
Net loss · FY 2023
₹3.23 Cr margin -56.1%
EBITDA · FY 2023
-₹2.51 Cr margin -43.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 53%
3 years · compounded
▼ 26%
5 years · compounded
▼ 22%
EBITDA CAGR growth
3 years · compounded
▲ 19%
5 years · compounded
▼ 27%
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years, including a 53% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.51 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -43.6% | ||||
| Net Profit Margin | -56.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Precia Pharma Private Limited, buy the company report.
Board of directors of Precia Pharma Private Limited
Precia Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Marotrao Pawar | Director | 14 Jul 2023 | 3 Years 3 Months | Current |
| Sanjay Marotrao Pawar Also directs: Precia Lifesciences Private Limited | Managing Director | 14 May 2010 | 16 Years 5 Months | Current |
Peer comparison
Precia Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nucleus Formulation Private Limited | ₹5.79 Cr (FY 2025) | 14.0% | Chhatral, Gujarat, India | |||
| Trexgen Pharmaceuticals Private Limited | ₹5.78 Cr (FY 2024) | 10.0% | Ahmedabad, Gujarat, India | |||
| Precia Pharma Private Limitedthis company | ₹5.77 Cr (FY 2023) | -₹3.23 Cr | -56.1% | -53.0% | 1 | Thane, Maharashtra, India |
| Mercury Pharmachem Industries Pvt Ltd | ₹5.77 Cr (FY 2024) | 426.0% | Panvel, Maharashtra, India |
To see the full peer comparison of Precia Pharma Private Limited, buy the company report.
Auditor
Precia Pharma Private Limited is audited by ARORA BEDI & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARORA BEDI & ASSOCIATES | FY 2021 | 012153C |
Shareholding
The shareholding of Precia Pharma Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Precia Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6.65 Cr
Satisfied charges
₹80 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Aug 2023 | 100784660 | Others | ₹3.55 Cr | Open | |
| 16 Aug 2018 | 100197741 | Others | ₹3.1 Cr | Open | |
| 12 Sep 2017 | 100125652 | Tjsb Sahakari Bank Limited | ₹80 Lakh | Satisfied |
To see the full charge records of Precia Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Precia Pharma Private Limited has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹2.5 Cr; the latest was in March 2016.
Total deals
2
Funding round
1
Rights issue
1
Disclosed funding
₹2.5 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Rights issue | ₹2.3 Cr | Investors: 4 individuals |
| Mar 2012 | Funding round | ₹2.5 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Precia Pharma Private Limited has 25 court cases on record: 25 filed against it. 8 cases are pending and 17 are disposed.
Total cases
25
Filed against the company
25
Pending
8
Disposed
17
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 25 | 25 | 8 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nagpur, Maharashtra | Civil suit | Filed against the company by Logistics Park India Private Limited | Pending |
| District court, West, Delhi | Cheque dishonour complaint | Filed against the company by Unimarck Healthcare Ltd Through Ar Inderjeet Sharma | Pending |
| District court, Nagpur, Maharashtra | Civil suit | Filed against the company by Hotel Hardeo Pvt Ltd, Through Its Directors, | Disposed |
| District court, Thane, Maharashtra | Criminal miscellaneous application | Filed against the company by Idfc First Bank Limited Through Its Authorized Officer Mr Sachin Salunke | Disposed |
| District court, South West, Delhi | Commercial suit | Filed against the company by Mascot Health Series Pvt Ltd | Disposed |
To see the full case history of Precia Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Precia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Precia Pharma Private Limited has a workforce of 1 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
Employee growth
-50%
GST
Precia Pharma has 7 GST registrations: 4 active and 3 cancelled or inactive.
Total GSTINs
7
Active
4
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCP7123F1ZI | Maharashtra | Active | 01 Jul 2017 |
| 22AAFCP7123F1ZS | Chhattisgarh | Active | 01 Jul 2017 |
| 23AAFCP7123F1ZQ | Madhya Pradesh | Active | 01 Jul 2017 |
| 24AAFCP7123F1ZO | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Precia Pharma Private Limited, buy the company report.
Recent activity
Precia Pharma Private Limited has 7 board changes on record since 2010: 2 appointments and 5 cessations. The latest: Anil Marotrao Pawar ceased to be Additional Director on 29 Sep 2023.
AGM
Precia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Ceased
Anil Marotrao Pawar ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 3.55 Cr with Charge ID 100784660 was registered on 31 Aug 2023.
Ceased
Manjusha Sanjay Pawar ceased to be Director.
Appointed
Anil Marotrao Pawar was appointed as Director.
Filing
Precia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Charges
A charge with Others of Rs. 3.10 Cr registered on 16 Aug 2018 with Charge ID 100197741 was modified on 19 Jul 2019.
Charges
A charge registered on 12 Sep 2017 via Charge ID 100125652 with Tjsb Sahakari Bank Limited was fully satisfied on 05 Oct 2018.
Charges
A charge with Others amounted to Rs. 3.10 Cr with Charge ID 100197741 was registered on 16 Aug 2018.
Charges
A charge with Tjsb Sahakari Bank Limited amounted to Rs. 0.80 Cr with Charge ID 100125652 was registered on 12 Sep 2017.
Ceased
Anup Omprakash Tapadiya ceased to be Additional Director.
Ceased
Sajid Akhtar Rafique Ahmed Shaikh ceased to be Additional Director.
3 earlier events are in the company report.
Frequently asked questions
Precia Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 May 2010 (16+ years old) and is registered under CIN U24233MH2010PTC203201.
Precia Pharma has 2 current directors:
- Sanjay Marotrao Pawar - Managing Director
- Anil Marotrao Pawar - Director
The latest financial statements of Precia Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Precia Pharma is 27AAFCP7123F1ZI, registered in Maharashtra. The company has 7 GST registrations in all, of which 4 are active and 3 are cancelled or inactive. Other active GSTINs include 22AAFCP7123F1ZS (Chhattisgarh), 23AAFCP7123F1ZQ (Madhya Pradesh), 24AAFCP7123F1ZO (Gujarat).
The CIN (Corporate Identification Number) of Precia Pharma is U24233MH2010PTC203201. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Precia Pharma has 25 court cases on record: 25 filed against it. 8 are pending.
Precia Pharma was incorporated on 14 May 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Precia Pharma has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹2.5 Cr; the latest was in March 2016.
The peers of Precia Pharma by revenue are Nucleus Formulation Private Limited, Trexgen Pharmaceuticals Private Limited, Mercury Pharmachem Industries Pvt Ltd, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anil Marotrao Pawar ceased to be Additional Director on 29 Sep 2023. Manjusha Sanjay Pawar ceased to be Director on 19 Jul 2023. Anil Marotrao Pawar was appointed as Director on 14 Jul 2023. Precia Pharma has 7 board changes on record in total.
Yes, Precia Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0242176).